CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 62 filers reported holding CUE BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $446,250 | +25.3% | 125,000 | 0.0% | 0.06% | -17.4% |
| Q4 2022 | $356,250 | -20.1% | 125,000 | -37.5% | 0.07% | -45.7% |
| Q3 2022 | $446,000 | +79.1% | 200,000 | +100.0% | 0.13% | +56.8% |
| Q2 2022 | $249,000 | -82.9% | 100,000 | -20.0% | 0.08% | -86.6% |
| Q2 2021 | $1,456,000 | +19.3% | 125,000 | +25.0% | 0.61% | +19.1% |
| Q1 2021 | $1,220,000 | -55.8% | 100,000 | -54.7% | 0.51% | -63.5% |
| Q4 2020 | $2,761,000 | -19.0% | 220,714 | -2.6% | 1.39% | -28.4% |
| Q3 2020 | $3,410,000 | +225.1% | 226,573 | +429.4% | 1.94% | +177.5% |
| Q2 2020 | $1,049,000 | +40.1% | 42,800 | -51.7% | 0.70% | -30.0% |
| Q1 2020 | $749,000 | -49.0% | 88,670 | -4.1% | 1.00% | +352.9% |
| Q4 2019 | $1,469,000 | – | 92,500 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
| SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
| P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
| Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
| Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
| APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
| Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
| CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
| Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |